Addex Therapeutics Statistics
Total Valuation
FRA:APE has a market cap or net worth of EUR 6.83 million. The enterprise value is 4.41 million.
Market Cap | 6.83M |
Enterprise Value | 4.41M |
Important Dates
The last earnings date was Monday, September 1, 2025.
Earnings Date | Sep 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 98.35M |
Shares Outstanding | n/a |
Shares Change (YoY) | +17.91% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 26.11M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 38.15 |
PB Ratio | 0.88 |
P/TBV Ratio | 0.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.68 |
EV / Sales | 24.69 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -2.86 |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.31 |
Quick Ratio | 2.03 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | -0.03 |
Interest Coverage | -1,161.92 |
Financial Efficiency
Return on equity (ROE) is -61.91% and return on invested capital (ROIC) is -15.09%.
Return on Equity (ROE) | -61.91% |
Return on Assets (ROA) | -13.55% |
Return on Invested Capital (ROIC) | -15.09% |
Return on Capital Employed (ROCE) | -32.72% |
Revenue Per Employee | 89,556 |
Profits Per Employee | -3.24M |
Employee Count | 2 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 0.05 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 49.29 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:APE had revenue of EUR 179,111 and -6.48 million in losses. Loss per share was -0.06.
Revenue | 179,111 |
Gross Profit | -110,900 |
Operating Income | -2.58M |
Pretax Income | -6.58M |
Net Income | -6.48M |
EBITDA | -2.49M |
EBIT | -2.58M |
Loss Per Share | -0.06 |
Balance Sheet
The company has 2.46 million in cash and 41,101 in debt, giving a net cash position of 2.42 million.
Cash & Cash Equivalents | 2.46M |
Total Debt | 41,101 |
Net Cash | 2.42M |
Net Cash Per Share | n/a |
Equity (Book Value) | 7.72M |
Book Value Per Share | 0.08 |
Working Capital | 1.61M |
Cash Flow
In the last 12 months, operating cash flow was -1.54 million and capital expenditures -1,363, giving a free cash flow of -1.54 million.
Operating Cash Flow | -1.54M |
Capital Expenditures | -1,363 |
Free Cash Flow | -1.54M |
FCF Per Share | n/a |
Margins
Gross Margin | -61.92% |
Operating Margin | -1,438.85% |
Pretax Margin | -3,675.86% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
FRA:APE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.91% |
Shareholder Yield | n/a |
Earnings Yield | -94.80% |
FCF Yield | -22.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |